Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033
Seeking Alpha · 市场快讯 · November 4, 2026 at 12:36 AM ET
Read the full report at the original publisher.
Seeking Alpha · 市场快讯 · November 4, 2026 at 12:36 AM ET
Read the full report at the original publisher.